Amgen Inc. (AMGN)
312.29
5.34 (1.74%)
At close: Mar 31, 2025, 2:23 PM
310.09
-0.70%
After-hours: Mar 31, 2025, 07:53 PM EDT
Repatha (evolocumab) Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 567M | 50M | +9.67% |
| Mar 31, 2024 | 517M | n/a | n/a |
| Dec 31, 2023 | n/a | n/a | n/a |
| Sep 30, 2023 | n/a | n/a | n/a |
| Jun 30, 2023 | n/a | n/a | n/a |
| Mar 31, 2023 | n/a | n/a | n/a |
| Dec 31, 2022 | n/a | n/a | n/a |
| Sep 30, 2022 | n/a | n/a | n/a |
| Jun 30, 2022 | n/a | n/a | n/a |
| Mar 31, 2022 | n/a | n/a | n/a |
| Dec 31, 2021 | n/a | n/a | n/a |
| Sep 30, 2021 | n/a | n/a | n/a |
| Jun 30, 2021 | n/a | n/a | n/a |
| Mar 31, 2021 | n/a | n/a | n/a |
| Sep 30, 2020 | n/a | n/a | n/a |
| Jun 30, 2020 | n/a | n/a | n/a |
| Mar 31, 2020 | n/a | n/a | n/a |
| Sep 30, 2019 | n/a | n/a | n/a |
| Jun 30, 2019 | n/a | n/a | n/a |
| Mar 31, 2019 | n/a | n/a | n/a |
| Sep 30, 2018 | n/a | n/a | n/a |
| Jun 30, 2018 | n/a | n/a | n/a |
| Mar 31, 2018 | n/a | n/a | n/a |